CLINICAL TRIALS PROFILE FOR TYENNE
✉ Email this page to a colleague
All Clinical Trials for TYENNE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT06863480 ↗ | Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events | NOT_YET_RECRUITING | University of Florida | PHASE1 | 2025-09-30 | In this study, tocilizumab-aazg (TYENNE) will be administered to see whether tocilizumab-aazg is safe in patients with a burst brain aneurysm and if it may prevent strokes in patients with a burst brain aneurysm. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TYENNE
Condition Name
Clinical Trial Locations for TYENNE
Trials by Country
Clinical Trial Progress for TYENNE
Clinical Trial Phase
Clinical Trial Sponsors for TYENNE
Sponsor Name
